skip to Main Content
My Account  Search by Structure    

Quanta BioDesign is the inventor of SuperHydrophilic™ dPEG® technology used to make superior life science reagents and assays.

Linker Architectures as Steric Auxiliaries for Altering Enzyme-Mediated Payload Realease from Bioconjugates.

Four Quanta BioDesign scientists – Matt Giese, Robert Woodman, Greg Hermanson, and Paul Davis – recently wrote an invited chapter for the book Chemical Linkers in Antibody-Drug Conjugates (ADCs), edited by Floris L. Van Delft and John M. Lambert (Royal Society of Chemistry, 2022).

Back To Top